Clinical outcomes, quality of life, advantages and disadvantages of metal stent placement in the upper gastrointestinal tract

Current Opinion in Supportive and Palliative Care

Volumn 6, Issue 1, 2012, Pages 27-32

  Vlavianos, Panagiotis ^a,b   Zabron, Abigail ^c  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Gastric outlet obstruction; Oesophageal stricture; Self expandable metal stents

Indexed keywords

DUODENUM DISEASE; ESOPHAGUS DISEASE; ESOPHAGUS STENOSIS; HUMAN; PATHOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; STENT; STOMACH DISEASE; STOMACH OBSTRUCTION; TIME; UPPER GASTROINTESTINAL TRACT;

DUODENAL DISEASES; ESOPHAGEAL DISEASES; ESOPHAGEAL STENOSIS; GASTRIC OUTLET OBSTRUCTION; HUMANS; QUALITY OF LIFE; STENTS; STOMACH DISEASES; TIME FACTORS; UPPER GASTROINTESTINAL TRACT;

EID: 84861818161     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32834f6004     Document Type: Review

References (43)

1. Knyrin K, Wagner H-J, Bethge N, et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 329:1302-1307.
2. Sharma P, Kozarek R; Practice Parameters Committee of the American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010; 105:258-273.
3. Morgan JL, Khan HN, Lambertz MM. Oesophageal stenting in a District General Hospital. Surgeon 2009; 1:203-205.
4. Selinger C, Ellul P, Smith P, Cole N. Oesophageal stent insertion for palliation of dysphagia in a District General Hospital: experience from a case series of 137 patients. QJM 2010; 103:545-548.
5. Van Boeckel P, Siersema P, Sturgess R, et al. A new partially covered metal stent for palliation of dysphagia: a prospective follow-up study. Gastrointest Endosc 2010; 72:1269-1273.
6. Madhusudhan C, Saluja S, Pal S. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus 2009; 22:331-336.
7. Bona D, Laface L, Bonavina L, et al. Covered nitinol stents for the treatment of esophageal strictures and leaks.World J Gastroenterol 2010; 16:2260-2264.
8. Verschuur E, Repici A, Kuipers E, et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008; 103:304-312.
9. Sreedharan A, Harris K, Crellin A, et al. Interventions for dysphagia in oesophageal cancer (review). Cochrane Library 2009; issue 4.
10. Uitdehaag M, van Hooft J, Verschuur E, et al. A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 2009; 70:1082-1089.
11. Paganin F, Schouler L, Cuissard L, et al. Airway and esophageal stenting in patients with advanced esophageal cancer and pulmonary involvement. PLoS One 2008; 3:e3101.
12. Blomberg J, Wenger U, Lagergren J, et al. Antireflux stent versus conventional stent in the palliation of distal esophageal cancer. A randomised, multicentre clinical trial. Scand J Gastroenterol 2010; 45:208-216.
13. Sgourakis G, Gockel I, Radtke A, et al. Self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and metaregression analysis of outcomes. Dig Dis Sci 2010; 55:3018-3030.
14. Shenfine J, McNamee P, Steen N, et al. A randomised controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol 2009; 104:1674-1685.
15. Javed A, Pal S, Dash N, et al. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial. J Gastrointest Cancer 2010 [Epub ahead of print].
16. Bower M, Jones W, Vessels B, et al. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy. Ann Surg Oncol 2009; 16:3161-3168.
17. Lopes TL, Eloubedi MA. A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer. Dis Esophagus 2010; 23:309-315.
18. Langer F, Schoppmann S, Prager G, et al. Temporary placement of selfexpanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol 2010; 12:470-475.
19. Tong D, Law S, Wong K. The use of self-expanding metallic stents (SEMS) is effective in symptom palliation from recurrent tumor after esophagogastrectomy from cancer. Dis Esophagus 2010; 23:660-665.
20. Van Heel N, Haringsma J, Spaander M, et al. Esophageal stents for the palliation of malignant fistula recurrence after esophagectomy. Gastrointest Endosc 2010; 72:249-254.
21. Thomas T, Abrams K, Subramanian V, et al. Esophageal stents for benign refractory strictures: a meta-analysis. Endoscopy 2011; 43:386-393.
22. Van Heel N, Haringsma J, Spaander M, et al. Short term esophageal stenting in the management of benign perforations. Am J Gastroenterol 2009; 105:1515-1520.
23. Repici A, Vleggaar F, Hassan C, et al. Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) Study. Gastrointest Endosc 2010; 72:927-934.
24. Kozareck R, Ball T, Patterson D. Metallic self-expanding stent application in the upper gastrointestinal tract: caveats and concerns. Gastrointest Endosc 1992; 38:1-6.
25. Topazian M, Ring E, Grendell J. Palliation of obstructing gastric cancer with steel mesh, self-expanding endoprosthesis. Gastrointest Endosc 1992; 38:58-60.
26. Dormann A, Meisner S, Verin N, Wenk Lang A. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004; 36:543-550.
27. Holt A, Patel M, Ahmed M. Palliation of patients with malignant gastroduodenal obstruction with self expanding metallic stents: the treatment of choice? Gastrointest Endosc 2004; 60:1010-1017.
28. Kim J, Song H-Y, Shin J, et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 2007; 66:256-264.
29. Seo E, Jung M, Park M, et al. Covered metal expandable nitinol stents for malignant gastroduodenal obstructions. J Gastroenterol Hepatol 2008; 23:1056-1062.
30. Lee K, Choi S, Shin S, et al. Palliative treatment of malignant gastroduodenal obstruction with metallic stent: prospective comparison of covered and uncovered stents. Scand J Gastroenterol 2009; 44:846-852.
31. Bang S, Kim H, Park Y, et al. Effectiveness of self-expanding metal stents for malignant antropyloric and duodenal obstruction with a comparison between covered and uncovered stents. Hepatogastroenterology 2008; 55:2091-2095.
32. Ko H, Song H, Shin J, et al. Fate of migrated esophageal and gastroduodenal stents: experience in 70 patients. J Vasc Interv Radiol 2007; 18:725-732.
33. Mittal A, Windsor J, Woodfield J, et al. Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg 2004; 91:205-209.
34. Del Piano M, Ballare M, Montino F, et al. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc 2005; 61:421-426.
35. Hosoni S, Ohtani H, Arimoto Y, et al. Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis. J Gastroenterol 2007; 42:283-290.
36. Jeurnink S, van Eijck C, Steyerberg E, et al. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007; 7:18.
37. Jeurnink S, Steyerberg E, van Hooft J, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010; 71:490-499.
38. Mehta S, Hindmarsh A, Cheong E, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 2006; 20:239-242.
39. Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antropyloric strictures. Gastroenterostomy versus endoscopic stenting. A randomized prospective trial. Antican Res 2004; 24:269-271.
40. Manes G, de Bellis M, Fuccio L, et al. Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of self-expanding metal stent. Arch Surg 2011; 146:1157-1162.
41. Small A, Coelho-Prabhu N, Baron T. Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest Endosc 2010; 71:560-572.
42. Geiger-Gritsch S, Stollenwerk B, Miksad B, et al. Safety of bevacizumab in patients with advanced cancer: a meta analysis of randomised controlled trials. Oncologist 2010; 15:1179-1191.
43. Rodrigues A, Diaz-Jimenez J. Malignant respiratory-digestive fistulas. Curr Opin Pulmon Med 2010; 16:329-333.